2024 Q2 Form 10-K Financial Statement
#000101738624000116 Filed on May 01, 2024
Income Statement
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
Revenue | $1.350K | $5.970K | $48.02K |
YoY Change | -92.31% | -71.75% | 2.61% |
Cost Of Revenue | $341.00 | $1.220K | $12.43K |
YoY Change | -92.79% | -78.63% | -1.93% |
Gross Profit | $1.009K | $4.750K | $35.60K |
YoY Change | -92.13% | -69.2% | 4.3% |
Gross Profit Margin | 74.74% | 79.56% | 74.12% |
Selling, General & Admin | $93.73K | $84.18K | $395.4K |
YoY Change | -16.73% | -59.85% | -21.61% |
% of Gross Profit | 9289.4% | 1772.21% | 1110.72% |
Research & Development | $0.00 | $8.501K | |
YoY Change | -100.0% | -29.59% | |
% of Gross Profit | 0.0% | 23.88% | |
Depreciation & Amortization | $240.00 | $240.00 | $984.00 |
YoY Change | 0.0% | 9.09% | 83.58% |
% of Gross Profit | 23.79% | 5.05% | 2.76% |
Operating Expenses | $93.73K | $84.17K | $403.9K |
YoY Change | -20.86% | -60.44% | -21.79% |
Operating Profit | -$92.72K | -$79.42K | -$368.3K |
YoY Change | -12.21% | -59.76% | -23.64% |
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | -$987.00 | -$1.990K | -$206.00 |
YoY Change | -286.23% | 541.94% | -115.37% |
Pretax Income | -$93.71K | -$81.41K | -$368.5K |
YoY Change | -10.83% | -58.81% | -23.38% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$93.71K | -$81.41K | -$368.5K |
YoY Change | -10.83% | -58.81% | -23.38% |
Net Earnings / Revenue | -6941.33% | -1363.65% | -767.26% |
Basic Earnings Per Share | $0.00 | $0.00 | |
Diluted Earnings Per Share | $0.00 | $0.00 | $0.00 |
COMMON SHARES | |||
Basic Shares Outstanding | 78.07M shares | 79.86M shares | 93.86M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $0.00 | $5.990K | $5.990K |
YoY Change | -100.0% | -95.67% | -95.67% |
Cash & Equivalents | $5.987K | ||
Short-Term Investments | |||
Other Short-Term Assets | $1.090K | $1.090K | $1.090K |
YoY Change | -6.84% | -96.45% | -96.45% |
Inventory | $10.23K | $13.66K | $13.66K |
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $11.32K | $20.73K | $20.73K |
YoY Change | -59.7% | -89.45% | -89.45% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $2.995K | $3.486K | $3.490K |
YoY Change | -24.71% | -22.01% | -21.92% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $2.995K | $3.486K | $3.490K |
YoY Change | -24.71% | -22.01% | -21.92% |
TOTAL ASSETS | |||
Total Short-Term Assets | $11.32K | $20.73K | $20.73K |
Total Long-Term Assets | $2.995K | $3.486K | $3.490K |
Total Assets | $14.32K | $24.22K | $24.22K |
YoY Change | -55.36% | -87.95% | -87.95% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $10.10K | $45.88K | $45.88K |
YoY Change | -47.64% | 2831.57% | 2822.29% |
Accrued Expenses | $14.95K | $14.56K | $112.7K |
YoY Change | 35.19% | 10.38% | 940.17% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $328.4K | $173.1K | $173.1K |
YoY Change | 489.61% | 576.36% | 576.4% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $328.4K | $173.1K | $173.1K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $328.4K | $173.1K | $173.1K |
YoY Change | 489.61% | 576.36% | 576.4% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$1.480M | -$1.305M | |
YoY Change | 28.09% | 39.34% | |
Common Stock | $78.08K | $79.86K | |
YoY Change | -10.1% | -28.59% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$314.1K | -$148.9K | -$148.9K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $14.32K | $24.22K | $24.22K |
YoY Change | -55.36% | -87.95% | -87.95% |
Cashflow Statement
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$93.71K | -$81.41K | -$368.5K |
YoY Change | -10.83% | -58.81% | -23.38% |
Depreciation, Depletion And Amortization | $240.00 | $240.00 | $984.00 |
YoY Change | 0.0% | 9.09% | 83.58% |
Cash From Operating Activities | -$25.16K | -$7.030K | -$173.6K |
YoY Change | -36.22% | -89.77% | -42.5% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $0.00 | |
YoY Change | -100.0% | -100.0% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $0.00 | ||
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $41.25K | ||
YoY Change | -81.67% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 24.04K | 5.250K | $41.25K |
YoY Change | -94.85% | -82.22% | |
NET CHANGE | |||
Cash From Operating Activities | -25.16K | -7.030K | -173.6K |
Cash From Investing Activities | 0.000 | ||
Cash From Financing Activities | 24.04K | 5.250K | $41.25K |
Net Change In Cash | -1.120K | -1.780K | -$132.3K |
YoY Change | -97.16% | -105.56% | 74.79% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$25.16K | -$7.030K | -$173.6K |
Capital Expenditures | $0.00 | $0.00 | |
Free Cash Flow | -$7.030K | -$173.6K | |
YoY Change | -89.96% | -43.59% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001703157 | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | scth |
Cancellation Of Common Shares
CancellationOfCommonShares
|
usd | |
CY2023 | scth |
Share Exchange Related Party
ShareExchangeRelatedParty
|
usd | |
CY2023 | scth |
Share Exchange Unrelated
ShareExchangeUnrelated
|
usd | |
CY2023 | scth |
Gain Loss On Disposition Of Assets2
GainLossOnDispositionOfAssets2
|
usd | |
CY2023 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
usd | |
CY2022 | scth |
Patent Royalty Contribution
PatentRoyaltyContribution
|
usd | |
CY2023 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
usd | |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2023 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
usd | |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2022 | us-gaap |
Stock Issued1
StockIssued1
|
usd | |
CY2022 | scth |
Stock Issued2
StockIssued2
|
usd | |
CY2023 | scth |
Stock Cancelled1
StockCancelled1
|
usd | |
CY2023Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
usd | |
CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
usd | |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
000-55927 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
SecureTech Innovations, Inc. | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
WY | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
82-0972782 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2355 Highway 36 West | |
CY2023 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 400 | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Roseville | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MN | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
55113 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
(651) 317-8990 | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
317-8990 | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
25480410 | usd |
CY2024Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
78071881 | shares |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Auditor Name
AuditorName
|
M&K CPAS, PLLC | |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
2738 | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
The Woodlands, TX | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5987 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
138318 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
13656 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
27549 | usd |
CY2023Q4 | us-gaap |
Deposit Assets
DepositAssets
|
1088 | usd |
CY2022Q4 | us-gaap |
Deposit Assets
DepositAssets
|
30674 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
20731 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
196541 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3486 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4470 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
24217 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
201011 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
45879 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1565 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
14564 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
13194 | usd |
CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
112328 | usd |
CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
5679 | usd |
CY2023Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
317 | usd |
CY2022Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
5153 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
173088 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
25591 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
173088 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
25591 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
3200 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
3200 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
3 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
79862655 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
79862655 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
111839085 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
111839085 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
79863 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
111839 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1076391 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1000239 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1305128 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-936658 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-148871 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
175420 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
24217 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
201011 | usd |
CY2023 | us-gaap |
Revenues
Revenues
|
48024 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
46803 | usd |
CY2023 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
12429 | usd |
CY2022 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
12674 | usd |
CY2023 | us-gaap |
Gross Profit
GrossProfit
|
35595 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
34129 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
395358 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
504316 | usd |
CY2023 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8501 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
12074 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
403859 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
516390 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-368264 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-482261 | usd |
CY2023 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-206 | usd |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1334 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-368470 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-480927 | usd |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
93857961 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
111929796 | shares |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
250504 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
225001 | usd |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.50 | |
CY2022 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
7000 | usd |
CY2022 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
173842 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-480927 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
175420 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
41250 | usd |
CY2023 | scth |
Patent Royalty Contribution
PatentRoyaltyContribution
|
2929 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-368470 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-148871 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-368470 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-480927 | usd |
CY2023 | us-gaap |
Depreciation
Depreciation
|
984 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
536 | usd |
CY2022 | scth |
Gain Loss On Disposition Of Assets2
GainLossOnDispositionOfAssets2
|
812 | usd |
CY2022 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
173842 | usd |
CY2023 | scth |
Patent Royalty Contribution
PatentRoyaltyContribution
|
2929 | usd |
CY2023 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
13893 | usd |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
12426 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
44314 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
405 | usd |
CY2023 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1370 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
13194 | usd |
CY2023 | us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
106649 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
5679 | usd |
CY2023 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
29586 | usd |
CY2022 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
-30674 | usd |
CY2023 | us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
-4836 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
2816 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-173581 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-301891 | usd |
CY2022 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
5818 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5818 | usd |
CY2023 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
41250 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
225001 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
7000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
41250 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
232001 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-132331 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-75708 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
138318 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
214026 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5987 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
138318 | usd |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2241 | usd |
CY2023 | us-gaap |
Stock Issued1
StockIssued1
|
25000 | usd |
CY2023 | scth |
Stock Issued2
StockIssued2
|
7000 | usd |
CY2022 | scth |
Stock Cancelled1
StockCancelled1
|
1700 | usd |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84A_eus-gaap--UseOfEstimates_zWruE233t7Cb" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities depends on future events, the preparation of financial statements for a period necessarily involves the use of estimates made using careful judgment. Actual results may vary from these estimates.</p> <p style="font: 10pt Times New Roman; margin: 0"> </p> | |
CY2023 | us-gaap |
Depreciation
Depreciation
|
984 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
536 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
984 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
536 | usd |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1520 | usd |
CY2023 | us-gaap |
Fiscal Period
FiscalPeriod
|
<p id="xdx_846_eus-gaap--FiscalPeriod_zYDdeM5l2zg8" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Fiscal Year</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The Company elected December 31st for its fiscal year-end.</p> <p style="font: 10pt Times New Roman; margin: 0"> </p> | |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1305128 | usd |
CY2023Q4 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
1925 | usd |
CY2022Q4 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
2185 | usd |
CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
11731 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
25364 | usd |
CY2023Q4 | us-gaap |
Inventory Gross
InventoryGross
|
13656 | usd |
CY2022Q4 | us-gaap |
Inventory Gross
InventoryGross
|
27549 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
13656 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
27549 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
274077 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
196698 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
274077 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
196698 | usd |
CY2023Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
1305128 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
250000 | shares |
CY2023 | us-gaap |
Preferred Stock Voting Rights
PreferredStockVotingRights
|
one (1) voting class of stock. Each share of Preferred Stock shall have ten thousand (10,000) votes | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
3200 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
3200 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
23570 | shares |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
41250 | usd |
CY2023Q4 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
1.75 | |
CY2023 | us-gaap |
Preferred Stock Conversion Basis
PreferredStockConversionBasis
|
3,200 | |
CY2023 | us-gaap |
Common Stock Conversion Basis
CommonStockConversionBasis
|
32,000,000 | |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
79862655 | shares |
CY2023 | scth |
Warrants Disclosure
WarrantsDisclosure
|
<p id="xdx_802_ecustom--WarrantsDisclosure_zjqZXpUfQbHl" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>NOTE 6 – WARRANTS</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">As of December 31, 2023, the Company had no warrants issued or outstanding.</p> <p style="font: 10pt Times New Roman; margin: 0"> </p> | |
CY2023Q4 | scth |
Accrued Payroll
AccruedPayroll
|
58500 | usd |
CY2023Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
4590 | usd |
CY2023 | scth |
Patent Royalty Contribution
PatentRoyaltyContribution
|
2929 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
5000 | shares |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
5000 | usd |
CY2024Q2 | us-gaap |
Share Price
SharePrice
|
1.00 | |
CY2024Q1 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
100000 | shares |
CY2024Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
3000 | usd |
CY2024Q1 | us-gaap |
Share Price
SharePrice
|
0.03 | |
CY2024Q1 | us-gaap |
Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
|
200 | shares |
CY2024Q1 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
1795774 | shares |